Journal of pharmaceutical health care and sciences

· 2 papers in corpus
case-report 2024
doi:10.1186/s40780-024-00361-x ·PMID:38987842

BACKGROUND: Among the oral antivirals used for treating patients with mild-to-moderate novel coronavirus disease 2019 (COVID-19), nirmatrelvir/ritonavir (NMV/RTV) and ensitrelvir (ESV) are inhibitors of cytochrome P450 (CYP) 3A, and therefo…

observational 2019
doi:10.1186/s40780-019-0141-7 ·PMID:31171976

To facilitate timely removal of urinary catheters and promote self-voiding among inpatients, urinary care teams have been established in some Japanese medical institutions. However, direct evidence of the effectiveness of pharmacist interve…